Drugs & Aging

, Volume 30, Issue 10, pp 793–807 | Cite as

Patient Barriers to and Enablers of Deprescribing: a Systematic Review

  • Emily Reeve
  • Josephine To
  • Ivanka Hendrix
  • Sepehr Shakib
  • Michael S. Roberts
  • Michael D. Wiese
Systematic Review

Abstract

Background

Inappropriate medication use is common in the elderly and the risks associated with their use are well known. The term deprescribing has been utilised to describe the complex process that is required for the safe and effective cessation of inappropriate medications. Given the primacy of the consumer in health care, their views must be central in the development of any deprescribing process.

Objectives

The aim of this study was to identify barriers and enablers that may influence a patient’s decision to cease a medication.

Data sources

A systematic search of MEDLINE, International Pharmaceutical Abstracts, EMBASE, CINAHL, Informit and Scopus was conducted and augmented with a manual search. Numerous search terms relating to withdrawal of medications and consumers’ beliefs were utilised.

Study eligibility criteria

Articles were included if the barriers or enablers were directly patient/carer reported and related to long-term medication(s) that they were currently taking or had recently ceased.

Study appraisal and synthesis methods

Determination of relevance and data extraction was performed independently by two reviewers. Content analysis with coding was utilised for synthesis of results.

Results

Twenty-one articles met the criteria and were included in the review. Three themes, disagreement/agreement with ‘appropriateness’ of cessation, absence/presence of a ‘process’ for cessation, and negative/positive ‘influences’ to cease medication, were identified as both potential barriers and enablers, with ‘fear’ of cessation and ‘dislike’ of medications as a fourth barrier and enabler, respectively. The most common barrier/enabler identified was ‘appropriateness’ of cessation, with 15 studies identifying this as a barrier and 18 as an enabler.

Conclusions and implications of key findings

The decision to stop a medication by an individual is influenced by multiple competing barriers and enablers. Knowledge of these will aid in the development of a deprescribing process, particularly in approaching the topic of cessation with the patient and what process should be utilised. However, further research is required to determine if the proposed patient-centred deprescribing process will result in improved patient outcomes.

Supplementary material

40266_2013_106_MOESM1_ESM.pdf (180 kb)
Supplementary material 1 (PDF 179 kb)

References

  1. 1.
    Guaraldo L, Cano FG, Damasceno GS, Rozenfeld S. Inappropriate medication use among the elderly: a systematic review of administrative databases. BMC Geriatrics. 2011;11:79.PubMedCrossRefGoogle Scholar
  2. 2.
    Elliott R. Problems with medication use in the elderly: an Australian perspective. J Pharm Pract Res. 2006;36:58–66.Google Scholar
  3. 3.
    Steinman MA, Landefeld CS, Rosenthal GE, Berthenthal D, Sen S, Kaboli PJ. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc. 2006;54:1516–23.PubMedCrossRefGoogle Scholar
  4. 4.
    Fialova D, Topinkova E, Gambassi G, Finne-Soveri H, Jonsson PV, Carpenter I, et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA. 2005;293:1348–58.PubMedCrossRefGoogle Scholar
  5. 5.
    Dedhiya SD, Hancock E, Craig BA, Doebbeling CC, Thomas J. Incident use and outcomes associated with potentially inappropriate medication use in older adults. Am J Geriatr Pharmacother. 2010;8:562–70.PubMedCrossRefGoogle Scholar
  6. 6.
    Chrischilles EA, VanGilder R, Wright K, Kelly M, Wallace RB. Inappropriate medication use as a risk factor for self reported adverse drug effects in older adults. J Am Geriatr Soc. 2009;57:1000–6.PubMedCrossRefGoogle Scholar
  7. 7.
    Holmes H. Rational prescribing for patients with a reduced life expectancy. Clin Pharmacol Ther. 2008;85:103–7.PubMedCrossRefGoogle Scholar
  8. 8.
    Dimitrow MS, Airaksinen MSA, Kivelä SL, Lyles A, Leikola SNS. Comparison of prescribing criteria to evaluate the appropriateness of drug treatment in individuals aged 65 and older: a systematic review. J Am Geriatr Soc. 2011;59:1521–30.PubMedCrossRefGoogle Scholar
  9. 9.
    Gnjidic D, Le Couteur DG, Kouladjian L, Hilmer SN. Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes. Clin Geriatr Med. 2012;28:237–53.PubMedCrossRefGoogle Scholar
  10. 10.
    Kaur S, Mitchell G, Vitetta L, Roberts MS. Interventions that can reduce inappropriate prescribing in the elderly: a systematic review. Drugs Aging. 2009;26:1013–28.PubMedCrossRefGoogle Scholar
  11. 11.
    Woodward M. Deprescribing: achieving better health outcomes for older people through reducing medications. J Pharm Pract Res. 2003;33:323–8.Google Scholar
  12. 12.
    Le Couteur DG, Banks E, Gnjidic D, McLachlan A. Deprescribing. Aust Prescr. 2011;34:182–5.Google Scholar
  13. 13.
    Iyer S, Naganathan V, McLachlan AJ, Le Couteur DG. Medication withdrawal trials in people aged 65 years and older: a systematic review. Drugs Aging. 2008;25:1021–31.PubMedCrossRefGoogle Scholar
  14. 14.
    Hering-Hanit R, Yavetz A, Dagan Y. Effect of withdrawal of misused medication on sleep disturbances in migraine sufferers with chronic daily headache. Headache. 2000;40:809–12.PubMedCrossRefGoogle Scholar
  15. 15.
    Alexander GC, Sayla MA, Holmes HM, Sachs GA. Prioritizing and stopping prescription medicines. Can Med Assoc J. 2006;174:1083–4.CrossRefGoogle Scholar
  16. 16.
    Bain KT, Holmes HM, Beers MH, Maio V, Handler SM, Pauker SG. Discontinuing medications: a novel approach for revising the prescribing stage of the medication-use process. J Am Geriatr Soc. 2008;56:1946–52.PubMedCrossRefGoogle Scholar
  17. 17.
    Ostini R, Hegney D, Jackson C, Tett SE. Knowing how to stop: ceasing prescribing when the medicine is no longer required. J Manage Care Pharm. 2012;18:68.Google Scholar
  18. 18.
    Scott I, Gray L, Martin J, Mitchell C. Minimizing inappropriate medications in older populations: a 10-step conceptual framework. Am J Med. 2012;125:529–37.PubMedCrossRefGoogle Scholar
  19. 19.
    Ostini R, Hegney D, Jackson C, Williamson M, Mackson JM, Gurman K, et al. Systematic review of interventions to improve prescribing. Ann Pharmacother. 2009;43:502–13.PubMedCrossRefGoogle Scholar
  20. 20.
    Reeve E, Wiese MD, Hendrix I, Roberts M, Shakib S. Patient attitudes, beliefs and experiences of polypharmacy and willingness of deprescribing. J Am Geriatr Soc. 2013 (accepted).Google Scholar
  21. 21.
    Beer C, Loh Pk, Peng YG, Potter K, Millar A. A pilot randomized controlled trial of deprescribing. Ther Adv Drug Saf. 2011;2:37–43.CrossRefGoogle Scholar
  22. 22.
    Williams M, Pulliam C, Hunter R, Johnson T, Owens J, Kincaid J, et al. The short-term effect of interdisciplinary medication review on function and cost in ambulatory elderly people. J Am Geriatr Soc. 2004;52:93–8.PubMedCrossRefGoogle Scholar
  23. 23.
    van Duijn HJ, Belo JN, Blom JW, Velberg ID, Assendelft WJ. Revised guidelines for cardiovascular risk management time to stop medication? A practice-based intervention study. Br J Gen Pract. 2011;61:e347–52.PubMedCrossRefGoogle Scholar
  24. 24.
    Gnjidic D, Le Couteur DG, Abernethy DR, Hilmer SN. A pilot randomized clinical trial utilizing the drug burden index to reduce exposure to anticholinergic and sedative medications in older people. Ann Pharmacother. 2010;44:1725–32.PubMedCrossRefGoogle Scholar
  25. 25.
    Fried TR, McGraw S, Agostini JV, Tinetti ME. Views of older persons with multiple morbidities on competing outcomes and clinical decision-making. J Am Geriatr Soc. 2008;56:1839–44.PubMedCrossRefGoogle Scholar
  26. 26.
    TRIP. Trip database. 2012. http://www.tripdatabase.com (Accessed 1 July 2013).
  27. 27.
    The Joanna Briggs Institute. Systematic review registered trials. University of Adelaide. 2013. http://www.joannabriggs.edu.au (Accessed 1 July 2013).
  28. 28.
    Dixon-Woods M, Bonas S, Booth A, Jones DR, Miller T, Sutton AJ, et al. How can systematic reviews incorporate qualitative research? A critical perspective. Qual Res. 2006;6:27–44.CrossRefGoogle Scholar
  29. 29.
    Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M et al. Guidance on the conduct of narrative synthesis in systematic reviews. Lancaster: Institute of Health Research, ESRC Methods Programme; 2006.Google Scholar
  30. 30.
    Dixon-Woods M, Fitzpatrick R, Roberts K. Including qualitative research in systematic reviews: opportunities and problems. J Eval Clin Pract. 2001;7:125–33.PubMedCrossRefGoogle Scholar
  31. 31.
    Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19:349–57.PubMedCrossRefGoogle Scholar
  32. 32.
    Straand J, Sandvik H. Stopping long-term drug therapy in general practice. How well do physicians and patients agree? Fam Pract. 2001;18:597–601.PubMedCrossRefGoogle Scholar
  33. 33.
    Barter G, Cormack M. The long-term use of benzodiazepines: patients’ views, accounts and experiences. Fam Pract. 1996;13:491–7.PubMedCrossRefGoogle Scholar
  34. 34.
    Cook JM, Biyanova T, Masci C, Coyne JC. Older patient perspectives on long-term anxiolytic benzodiazepine use and discontinuation: a qualitative study. J Gen Intern Med. 2007;22:1094–100.PubMedCrossRefGoogle Scholar
  35. 35.
    Iliffe S, Curran HV, Collins R, Kee SC, Fletcher S, Woods B. Attitudes to long-term use of benzodiazepine hypnotics by older people in general practice: findings from interviews with service users and providers. Aging Ment Health. 2004;8:242–8.PubMedCrossRefGoogle Scholar
  36. 36.
    King MB, Gabe J, Williams P, Rodrigo EK. Long term use of benzodiazepines: the views of patients. Br J Gen Pract. 1990;40:194–6.PubMedGoogle Scholar
  37. 37.
    Parr JM, Kavanagh DJ, Young RM, McCafferty K. Views of general practitioners and benzodiazepine users on benzodiazepines: a qualitative analysis. Soc Sci Med. 2006;62:1237–49.PubMedCrossRefGoogle Scholar
  38. 38.
    Roe D, Goldblatt H, Baloush-Klienman V, Swarbrick M, Davidson L. Why and how people decide to stop taking prescribed psychiatric medication: exploring the subjective process of choice. Psychiatr Rehabil J. 2009;33:38–46.PubMedCrossRefGoogle Scholar
  39. 39.
    Moses T. Adolescents’ commitment to continuing psychotropic medication: a preliminary investigation of considerations, contradictions, and correlates. Child Psychiatry Hum Dev. 2011;42:93–117.PubMedCrossRefGoogle Scholar
  40. 40.
    Haslam C, Brown S, Atkinson S, Haslam R. Patients’ experiences of medication for anxiety and depression: effects on working life. Fam Pract. 2004;21:204–12.PubMedCrossRefGoogle Scholar
  41. 41.
    Leydon GM, Rodgers L, Kendrick T. A qualitative study of patient views on discontinuing long-term selective serotonin reuptake inhibitors. Fam Pract. 2007;24:570–5.PubMedCrossRefGoogle Scholar
  42. 42.
    Verbeek-Heida P, Mathot E. Better safe than sorry—why patients prefer to stop using selective serotonin reuptake inhibitor (SSRI) antidepressants but are afraid to do so: results of a qualitative study. Chronic Illn. 2006;2:133–42.PubMedGoogle Scholar
  43. 43.
    Post SG, Stuckey JC, Whitehouse PJ, Ollerton S, Durkin C, Robbins D, et al. A focus group on cognition-enhancing medications in Alzheimer disease: disparities between professionals and consumers. Alzheimer Dis Assoc Disord. 2001;15:80–8.PubMedCrossRefGoogle Scholar
  44. 44.
    Gold ML, Sorences JL, McCanlies N, Trier M, Dlugosch G. Tapering from methadone maintenance: Attitudes of clients and staff. J Subst Abuse Treat. 1988;5:37–44.PubMedCrossRefGoogle Scholar
  45. 45.
    Kilinç S, Campbell C. The experience of discontinuing antiepileptic drug treatment: An exploratory investigation. Seizure. 2008;17:505–13.PubMedCrossRefGoogle Scholar
  46. 46.
    Bertero C, Johansson G. Compliance with hormone replacement therapy among Swedish women. Int Nurs Rev. 2001;48:224–32.PubMedCrossRefGoogle Scholar
  47. 47.
    Castelo-Branco C, Ferrer J, Palacios S, Cornago S, Peralta S. Spanish post-menopausal women’s viewpoints on hormone therapy. Maturitas. 2007;56:420–8.PubMedCrossRefGoogle Scholar
  48. 48.
    Horner E, Fleming J, Studd J. A study of women on long-term hormone replacement therapy and their attitude to suggested cessation. Climacteric. 2006;9:459–63.PubMedCrossRefGoogle Scholar
  49. 49.
    Boath EH, Blenkinsopp A. The rise and rise of proton pump inhibitor drugs: patients’ perspectives. Soc Sci Med. 1997;45:1571–9.PubMedCrossRefGoogle Scholar
  50. 50.
    Grime J, Pollock K, Blenkinsopp A. Proton pump inhibitors: perspectives of patients and their GPs. Br J Gen Pract. 2001;51:703.PubMedGoogle Scholar
  51. 51.
    Berger BA, Hudmon KS, Liang H. Predicting treatment discontinuation among patients with multiple sclerosis: application of the transtheoretical model of change. J Am Pharm Assoc. 2004;44:445–54.CrossRefGoogle Scholar
  52. 52.
    Benson J, Britten N. Patients’ decisions about whether or not to take antihypertensive drugs: qualitative study. BMJ. 2002;325:873.PubMedCrossRefGoogle Scholar
  53. 53.
    O’Connor M, Gallagher P, O’Mahony D. Inappropriate prescribing: criteria, detection and prevention. Drugs Aging. 2012;29:437.PubMedCrossRefGoogle Scholar
  54. 54.
    Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD. Development and validation of the patients’ attitudes towards deprescribing (PATD) questionnaire. Int J Clin Pharm. 2013;35:51–6.PubMedCrossRefGoogle Scholar
  55. 55.
    Dolovich L, Nair K, Sellors C, Lohfeld L, Lee A, Levine M. Do patients’ expectations influence their use of medications? Qualitative study. Can Fam Physician. 2008;54:384–93.PubMedGoogle Scholar
  56. 56.
    Morecroft C, Cantrill J, Tully MP. Patients’ evaluation of the appropriateness of their hypertension management—a qualitative study. Res Social Adm Pharm. 2006;2:186–211.PubMedCrossRefGoogle Scholar
  57. 57.
    Krol N, Wensing M, Haaijer-Ruskamp F, Muris JW, Numans ME, Schattenberg G, et al. Patient-directed strategy to reduce prescribing for patients with dyspepsia in general practice: a randomized trial. Aliment Pharmacol Ther. 2004;19:917–22.PubMedCrossRefGoogle Scholar
  58. 58.
    Haddad P. Do antidepressants have any potential to cause addiction? J Psychopharmacol. 1999;13:300–7.PubMedCrossRefGoogle Scholar
  59. 59.
    Charach A, Skyba A, Cook L, Antle BJ. Using stimulant medication for children with ADHD: What do parents say? A brief report. J Can Acad Child Adolesc Psychiatry. 2006;15:75–83.PubMedGoogle Scholar
  60. 60.
    Graves T, Hanlon JT, Schmader KE, Landsman PB, Samsa GP, Pieper CF, et al. Adverse events after discontinuing medications in elderly outpatients. Arch Intern Med. 1997;157:2205–10.PubMedCrossRefGoogle Scholar
  61. 61.
    Inadomi JM, Jamal R, Murata GH, Hoffman RM, Lavezo LA, Vigil JM, et al. Step-down management of gastroesophageal reflux disease. Gastroenterology. 2001;121:1095–100.PubMedCrossRefGoogle Scholar
  62. 62.
    Raghunath A, Hungin A, Cornford C, Featherstone V. Use of proton pump inhibitors: an exploration of the attitudes, knowledge and perceptions of general practitioners. Digestion. 2005;72:212–8.PubMedCrossRefGoogle Scholar
  63. 63.
    Bashir K, King M, Ashworth M. Controlled evaluation of brief intervention by general practitioners to reduce chronic use of benzodiazepines. Br J Gen Pract. 1994;44:408–12.PubMedGoogle Scholar
  64. 64.
    Espeland MA, Whelton PK, Kostis JB, Bahnson JL, Ettinger WH, Cutler JA, et al. Predictors and mediators of successful long-term withdrawal from antihypertensive medications. Arch Fam Med. 1999;8:228–36.PubMedCrossRefGoogle Scholar
  65. 65.
    Hesse BW, Nelson DE, Kreps GL, Croyle RT, Arora NK, Rimer BK, et al. Trust and sources of health information: the impact of the Internet and its implications for health care providers: findings from the first Health Information National Trends Survey. Arch Intern Med. 2005;165:2618.PubMedCrossRefGoogle Scholar
  66. 66.
    Zermansky AG. Who controls repeats? Br J Gen Pract. 1996;46:643.PubMedGoogle Scholar
  67. 67.
    Schuling J, Gebben H, Veehof LJG, Haaijer-Ruskamp FM. Deprescribing medication in very elderly patients with multimorbidity: the view of Dutch GPs. A qualitative study. BMC Fam Pract. 2012;13:56.PubMedCrossRefGoogle Scholar
  68. 68.
    Mays N, Pope C. Assessing quality in qualitative research. BMJ. 2000;320:50–2.PubMedCrossRefGoogle Scholar
  69. 69.
    Meeks TW, Culberson JW, Horton MS. Medications in long-term care: when less is more. Clin Geriatr Med. 2011;27:171–91.PubMedCrossRefGoogle Scholar
  70. 70.
    Hardy JE, Hilmer SN. Deprescribing in the last year of life. J Pharm Pract Res. 2011.Google Scholar
  71. 71.
    Naunton M, Peterson GM, Bleasel MD. Overuse of proton pump inhibitors. J Clin Pharm Ther. 2000;25:333–40.PubMedCrossRefGoogle Scholar
  72. 72.
    Poses RM, Isen AM. Qualitative research in medicine and health care. J Gen Intern Med. 1998;13:32–8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2013

Authors and Affiliations

  • Emily Reeve
    • 1
    • 2
    • 3
  • Josephine To
    • 2
  • Ivanka Hendrix
    • 4
  • Sepehr Shakib
    • 3
  • Michael S. Roberts
    • 1
    • 5
  • Michael D. Wiese
    • 1
    • 2
  1. 1.Sansom InstituteUniversity of South AustraliaAdelaideAustralia
  2. 2.School of Pharmacy and Medical SciencesUniversity of South AustraliaAdelaideAustralia
  3. 3.Department of Clinical PharmacologyRoyal Adelaide HospitalAdelaideAustralia
  4. 4.Pharmacy DepartmentRepatriation General HospitalDaw ParkAustralia
  5. 5.Therapeutics Research Centre, School of MedicineUniversity of QueenslandBrisbaneAustralia

Personalised recommendations